Giuseppe Viale

Division of Pathology, IEO, European Institute of Oncology IRCCS

Affiliated withIEO, European Institute of Oncology IRCCS University of Milan

Research Area

Cancer Research

Biography

Giuseppe Viale has not added Biography.
If you are Giuseppe Viale and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

Article Total : 1	Year
Publication title	2022

Other Publications

Article	Year
What can the pathologist offer for optimal treatment choice? Annals of oncology : official journal of the European Society for Medical Oncology\| PubMed ID: 20943626	2010
Which patients benefit most from adjuvant aromatase inhibitors? Results using a composite measure of prognostic risk in the BIG 1-98 randomized trial. Annals of oncology : official journal of the European Society for Medical Oncology\| PubMed ID: 21335417	2011
Pathological work up of the primary tumor: getting the proper information out of it. Breast (Edinburgh, Scotland)\| PubMed ID: 22015299	2011
The current state of breast cancer classification. Annals of oncology : official journal of the European Society for Medical Oncology\| PubMed ID: 22987963	2012
Experts' opinion: Recommendations for retesting breast cancer metastases for HER2 and hormone receptor status. Breast (Edinburgh, Scotland)\| PubMed ID: 23352656	2013
Characterization and clinical impact of residual disease after neoadjuvant chemotherapy. Breast (Edinburgh, Scotland)\| PubMed ID: 24074800	2013
High concordance of protein (by IHC), gene (by FISH; HER2 only), and microarray readout (by TargetPrint) of ER, PgR, and HER2: results from the EORTC 10041/BIG 03-04 MINDACT trial. Annals of oncology : official journal of the European Society for Medical Oncology\| PubMed ID: 24667714	2014
Molecular analysis of sentinel lymph nodes and search for molecular signatures of the metastatic potential of breast cancer. The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of...\| PubMed ID: 24835292	2014
A bad tumor biomarker is as bad as a bad drug: The gap between genomics data and phenotype to predict response. Breast (Edinburgh, Scotland)\| PubMed ID: 26255744	2015
Negatively charged AuNP modified with monoclonal antibody against novel tumor antigen FAT1 for tumor targeting. Journal of experimental & clinical cancer research : CR\| PubMed ID: 26373379	2015
Predictive value and clinical utility of centrally assessed ER, PgR, and Ki-67 to select adjuvant endocrine therapy for premenopausal women with hormone receptor-positive, HER2-negative earl... Breast cancer research and treatment\| PubMed ID: 26493064	2015
ESR1 and ESR2 polymorphisms in the BIG 1-98 trial comparing adjuvant letrozole versus tamoxifen or their sequence for early breast cancer. Breast cancer research and treatment\| PubMed ID: 26590813	2015
Discordant assessment of tumor biomarkers by histopathological and molecular assays in the EORTC randomized controlled 10041/BIG 03-04 MINDACT trial breast cancer : Intratumoral heterogeneit... Breast cancer research and treatment\| PubMed ID: 26820652	2016
HER2 status predicts for upfront AI benefit: A TRANS-AIOG meta-analysis of 12,129 patients from ATAC, BIG 1-98 and TEAM with centrally determined HER2. European journal of cancer (Oxford, England : 1990)\| PubMed ID: 28494403	2017
Controversies in treatment selection for patients with equivocal ER and HER2 results. Breast (Edinburgh, Scotland)\| PubMed ID: 28666922	2017
Immunohistochemical versus molecular (BluePrint and MammaPrint) subtyping of breast carcinoma. Outcome results from the EORTC 10041/BIG 3-04 MINDACT trial. Breast cancer research and treatment\| PubMed ID: 28929359	2018
Molecular Profile of Advanced Non-Small Cell Lung Cancers in Octogenarians: The Door to Precision Medicine in Elderly Patients. Journal of clinical medicine\| PubMed ID: 30669267	2019
Clinical and analytical validation of Ki-67 in 9069 patients from IBCSG VIII + IX, BIG1-98 and GeparTrio trial: systematic modulation of interobserver variance in a comprehensive in silico r... Breast cancer research and treatment\| PubMed ID: 31065870	2019
Ki-67 (30-9) scoring and differentiation of Luminal A- and Luminal B-like breast cancer subtypes. Breast cancer research and treatment\| PubMed ID: 31422497	2019
Tumor BRCA Test for Patients with Epithelial Ovarian Cancer: The Role of Molecular Pathology in the Era of PARP Inhibitor Therapy. Cancers\| PubMed ID: 31653094	2019
Treatment selection for patients with equivocal HER2 status and in luminal versus HER2-enriched disease. Breast (Edinburgh, Scotland)\| PubMed ID: 31839160	2019
DNA methylation markers predict recurrence-free interval in triple-negative breast cancer. NPJ breast cancer\| PubMed ID: 32025567	2020
Independent Validation of EarlyR Gene Signature in BIG 1-98: A Randomized, Double-Blind, Phase III Trial Comparing Letrozole and Tamoxifen as Adjuvant Endocrine Therapy for Postmenopausal Wo... JNCI cancer spectrum\| PubMed ID: 32337480	2019
Application of a risk-management framework for integration of stromal tumor-infiltrating lymphocytes in clinical trials. NPJ breast cancer\| PubMed ID: 32436923	2020
Gut vascular barrier impairment leads to intestinal bacteria dissemination and colorectal cancer metastasis to liver. Cancer cell\| PubMed ID: 33798472	2021
Patient-reported function, health-related quality of life, and symptoms in APHINITY: pertuzumab plus trastuzumab and chemotherapy in HER2-positive early breast cancer. British journal of cancer\| PubMed ID: 33828257	2021
Intraoperative irradiation for early breast cancer (ELIOT): long-term recurrence and survival outcomes from a single-centre, randomised, phase 3 equivalence trial. The Lancet. Oncology\| PubMed ID: 33845035	2021
Heparanase: a potential marker of worse prognosis in estrogen receptor-positive breast cancer. NPJ breast cancer\| PubMed ID: 34050190	2021
Economic implications of ACOSOG Z0011 trial application into clinical practice at the European Institute of Oncology. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology\| PubMed ID: 34172359	2021
Early Breast Cancers During Pregnancy Treated With Breast-Conserving Surgery in the First Trimester of Gestation: A Feasibility Study. Frontiers in oncology\| PubMed ID: 34504801	2021
Pathology after neoadjuvant treatment - How to assess residual disease. Breast (Edinburgh, Scotland)\| PubMed ID: 34810049	2022
Breast Cancer during Pregnancy as a Special Type of Early-Onset Breast Cancer: Analysis of the Tumor Immune Microenvironment and Risk Profiles. Cells\| PubMed ID: 35892583	2022
Comparison of HercepTest™ mAb pharmDx (Dako Omnis, GE001) with Ventana PATHWAY anti-HER-2/neu (4B5) in breast cancer: correlation with HER2 amplification and HER2 low status. Virchows Archiv : an international journal of pathology\| PubMed ID: 35970977	2022